Short answer
As of October 2026, whether a telehealth brand's care is asynchronous or synchronous changes its advertising in two ways: how platforms and LegitScript categorize the business, and where patient health information enters the funnel. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats the care model as an input to the media plan: async concentrates the risk in the intake flow, and synchronous moves it into scheduling.
Why does the care model change a telehealth media plan?
Founders reasonably treat the choice between asynchronous and synchronous care as a clinical and operational decision. MedScale works with telehealth brands and clinics, and the decision reliably shows up in advertising too, because it changes both how a platform classifies the business and where sensitive information enters the funnel.
Neither care model is easier to advertise in the abstract. The two are constrained differently, and the constraints are easier to manage when they are anticipated rather than discovered.
Where is the advertising risk in asynchronous telehealth care?
An asynchronous model typically routes the patient through a structured intake questionnaire that a clinician reviews later. The questionnaire is usually the first point at which the business holds specific health information about an identifiable person, and it usually sits on the marketing site rather than inside a clinical system.
Intake answers on the marketing site are the defining advertising problem for async brands. The intake is instrumented like a marketing funnel because it was built by a growth team, while its contents are the most sensitive data the business collects. Sending step-level events from that flow to an advertising platform without deliberate filtering is the most common way a telehealth brand creates exposure it did not intend.
Meta's Business Tools terms list medical conditions, treatments and prescription medications among the information advertisers must not send, and Meta can place a pixel into a core setup that blocks custom parameters and everything in a URL after the domain. An intake that puts answers into URLs or event names triggers exactly that. MedScale reviews any intake quiz its ads point at as part of the ad, before the campaign goes live.
Where is the advertising risk in synchronous telehealth care?
A synchronous model usually converts on a booked appointment, which shifts the sensitive moment from a questionnaire to a scheduling system. The volume of health information captured before conversion is often lower, which simplifies the tracking question.
The trade-off for synchronous care is a longer and more fragile path to conversion, with appointment availability and no-show behavior sitting between the click and the outcome the business actually cares about. Optimizing toward a booking that frequently does not happen is its own expensive failure, so MedScale reports attended visits, not only bookings, for synchronous clients.
How does the care model change ad measurement?
Async and synchronous models want different conversion architectures, and copying one from the other is a common and costly mistake. MedScale keeps leads and treated patients as separate lines in campaign reporting for both.
- Async brands need intake events that indicate progress without transmitting the clinical content of answers.
- Synchronous brands need attribution that survives the gap between booking and attendance.
- Both need the distinction between a lead and a treated patient to be visible in reporting, because optimizing to the first reliably degrades the second.
- Both send events server-side, under a business associate agreement, with neutral names. No names, emails, phone numbers, IP addresses or browser IDs go to the ad platforms.
Does the care model change which certifications you need?
Certification requirements attach to what the business does rather than to how it describes itself, and both models can fall within scope where the funnel results in a prescription. The care model does affect the documentation required and how the business is categorized, so it is worth confirming requirements against the actual clinical workflow rather than against the marketing positioning.
Two rules make the care model matter more. LegitScript's terms bar prescribing without a valid prescription, including a legitimate practitioner-patient relationship, so a questionnaire-only model has to match each state's law. And where the model prescribes a controlled substance without an in-person visit, it rests on the DEA's temporary telemedicine flexibilities, which the fourth extension, Federal Register document 2025-24123, runs through December 31, 2026. MedScale checks the care model against both rules before planning prescription campaigns.
How should a telehealth brand choose a care model with advertising in mind?
A care model should not be chosen on marketing grounds, but its growth constraints should be known when the clinical decision is made, because retrofitting compliant measurement onto an intake flow that was instrumented without it is considerably more expensive than building it correctly at the start. MedScale treats the care model as an input to the media plan for that reason.
Common questions
- 01Can I track intake quiz completions in Meta or Google?
- Yes, as progress, not content. Progress events can generally be tracked, but the content of clinical answers should not be transmitted to an advertising platform. The workable pattern is to report that a step was completed without reporting what was answered, which keeps health information out of the ad stack.
- 02Is asynchronous care harder to advertise than synchronous care?
- No, neither model is uniformly harder. Async concentrates risk in an intake flow that usually sits on the marketing site, while synchronous shifts it into scheduling and introduces a longer, more fragile conversion path. The costs are different rather than one being larger.
- 03Does the care model change which certifications I need?
- Usually not the certification itself: both models commonly fall within scope where the funnel ends in a prescription, but the model can change the documentation required and how the business is categorized. Confirm requirements against the actual clinical workflow rather than against how the brand positions itself.
- 04Should I optimize campaigns to intake starts or completed consultations?
- Usually neither extreme. Optimizing to the earliest event produces volume that does not convert to treated patients, while optimizing to the latest can starve the platform of signal. Most telehealth accounts need an intermediate event that correlates with genuine intent and occurs often enough to train delivery.
Sources
- 01Meta Business Help Center: About prohibited information (health data in Business Tools)checked October 5, 2026
- 02Google Ads policy: Prescription drug serviceschecked October 5, 2026
- 03LegitScript: Healthcare Certification terms and conditionschecked October 5, 2026
- 04Meta Advertising Standards: Drugs and Pharmaceuticalschecked October 5, 2026
- 05Federal Register 2025-24123: Fourth temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications (through Dec 31, 2026)checked October 5, 2026
Related answers
How Do Meta, Google and TikTok Differ on Telehealth Advertising?
As of October 2026, Google gates telehealth ads at the advertiser (LegitScript and Google certification), Meta at the content (plus LegitScript and authorization for prescription drug ads), and TikTok at the product (US prescription ads need proof of FDA approval). MedScale Health, a paid ads agency for US telehealth brands and clinics, plans the channel mix around those three gates and runs TikTok only for non-prescription offers. Compounded drugs cannot meet TikTok's rule, and its prescription ads must target people 18 or older.
Reviewed October 24, 2026
How Do You Advertise a Telehealth Brand on Meta Without Losing the Ad Account?
As of October 2026, keeping a telehealth ad account healthy on Meta comes down to three habits: never write copy that implies knowledge of the viewer's health, never send traffic to a page that contradicts the ad, and track disapproval rate as a metric. MedScale Health, a paid ads agency for US telehealth brands and clinics, finds that accounts are almost never lost to a single bad ad but to an accumulating pattern of disapprovals nobody was tracking.
Reviewed October 24, 2026
Who Needs LegitScript Certification to Advertise Telemedicine?
As of November 2026, US telemedicine providers need LegitScript certification before Google or Meta will run their prescription-drug advertising, and online pharmacies need it for Meta and LegitScript or NABP for Google. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats certification as a launch dependency, because campaigns planned around an uncertified account will not deliver. Google names LegitScript as the accreditation for US telemedicine providers, and Meta requires active LegitScript certification plus its own authorization to promote a prescription drug.
Reviewed November 9, 2026
Last reviewed October 24, 2026. Platform policies change often; we re-verify every answer quarterly.